SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-067012
Filing Date
2017-11-08
Accepted
2017-11-08 16:35:45
Documents
3
Period of Report
2017-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-26176_28k.htm 8-K 37849
2 EX-99.1 a17-26176_2ex99d1.htm EX-99.1 80611
3 GRAPHIC g261762mmi001.jpg GRAPHIC 2594
  Complete submission text file 0001104659-17-067012.txt   123309
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 171187070
SIC: 2834 Pharmaceutical Preparations